Home World News Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid Cancer World News Postoperative Radioiodine Can Be Avoided in Patients with Low-Risk Differentiated Thyroid Cancer By Ogkologos - August 12, 2025 783 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IoN study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR 74 & 75-Year-Old Sweethearts Get Married In ICU In Wake Of... February 10, 2022 Today is Giving Tuesday December 1, 2020 Primary Tumour Resection Does Not Prolong OS in Patients with Treatment-Naïve... March 7, 2024 Over 600 people in England set to benefit from innovative lung... December 1, 2021 Load more HOT NEWS Opinion: ‘Wales needs more than a three-page statement to get cancer... Cancer in My Community: Bringing Palliative Care to People With Cancer... We have a Deal: What does the new UK-EU relationship mean... Tucatinib Added to Trastuzumab and Capecitabine Continues to Demonstrate a Significant...
